When abnormal cells stay inside the milk ducts and do not spread to nearby tissue, the condition is ductal carcinoma in situ (DCIS), also known as intraductal carcinoma or pre-invasive breast cancer. DCIS is the earliest stage of breast cancer, stage 0 breast cancer. DCIS does not spread to the lymph nodes or metastasize (meaning it doesn't spread to other parts of the body).
The Ductal Carcinoma in Situ program at Dana-Farber Brigham Cancer Center offers specialized care and resources for people diagnosed with this earliest form of breast cancer. This program, the only of its kind in New England, combines patient care with in-depth research and educational resources to provide personalized care for each patient's unique needs. The comprehensive care team from both Brigham and Women's Hospital and Dana-Farber Cancer Institute, includes breast cancer surgeons, medical oncologists and radiation oncologists, as well as dedicated physician assistants and nurse practitioners.
Learn more about the Ductal Carcinoma in Situ program.